Vitrolife AB (0YAY)

294.90
-9.50(-3.12%)
  • Volume:
    13,432
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    294.90 - 294.90

0YAY Overview

Prev. Close
304.4
Day's Range
294.9-294.9
Revenue
-
Open
304.8
52 wk Range
201.4-585
EPS
2.73
Volume
13,432
Market Cap
39.94B
Dividend (Yield)
0.80
(0.26%)
Average Volume (3m)
44,069
P/E Ratio
105.38
Beta
1.2
1-Year Change
-37.15%
Shares Outstanding
135,394,622
Next Earnings Date
26 Oct 2022
What is your sentiment on Vitrolife?
or
Market is currently closed. Voting is open during market hours.

Vitrolife AB Company Profile

Vitrolife AB Company Profile

Employees
1200
Market
Sweden

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellSell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellSellStrong Sell